This disclosure provides crystalline polymorphs of squalamine phosphate, methods of making the same, and methods of treatment using the same.
-
(2021/09/26)
NEW SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME
Provided herein are crystalline solid forms of squalamine phosphate designated as Form 1 and Form 2, compositions containing one or both forms, and methods of their preparation and of their use.
-
Paragraph 0228-0234
(2019/05/15)
Polymorphic and amorphous salt forms of squalamine dilactate
The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dil
-
Page/Page column 10-11
(2010/11/25)
More Articles about upstream products of 320725-47-1
Get Best Price for320725-47-1(2S)-2-hydroxypropanoic acid - (3beta,5alpha,7alpha,24R)-3-({3-[(4-aminobutyl)amino]propyl}amino)-7-hydroxycholestan-24-yl hydrogen sulfate (1:1)